Vorinostat and IV Fluorouracil/Leucovorin (5FU/LV) in Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This protocol will investigate the use of vorinostat (suberoylanilide hydroxamic acid - SAHA)
in combination with infusional 5-FU and leucovorin for the treatment of metastatic colorectal
cancer patients who have failed standard 5FU regimens.